Emergent Biosolutions Inc (EBS)
EBITDA
-$700.00K
TTM · Period ending: · USD
EBS EBITDA
Latest reported-$700.00Kperiod ending
Latest reported-$700.00Kperiod ending
EBS EBITDA ($45.31M → -$700.00K)
Annual EBITDA
High-resolution chart · PNG
EBS ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 237,900,000 | |
| 56,600,000 | |
| -43,000,000 | |
| 34,000,000 | |
| 509,800,000 | |
| 613,700,000 | |
| 261,600,000 | |
| 155,100,000 | |
| 174,700,000 | |
| 132,900,000 | |
| 186,676,000 | |
| 121,641,000 | |
| 65,060,000 | |
| 47,759,000 | |
| 41,298,000 | |
| 79,356,000 | |
| 46,517,000 | |
| 37,024,000 | |
| 37,910,000 | |
| 43,882,000 | |
| 25,425,000 | |
| 18,709,000 | |
| 55,769,000 | |
| 37,767,000 | |
| 45,309,000 |